In addition, BITC did neither significantly affect cyclin D1 expression in HCT-116 p53+/+ cells, nor significantly increase their viability, although further studies are needed to check whether BITC increases cancer risk in the other p53-positive cell lines and tissues. This evidence concerns the gene TP53 and cancer.